Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02203331 · ClinicalTrials.gov registry record · Phase 2
Bay98-7196, Dose Finding / POC Study
A Phase 2 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 2
- Development phase
- 319
- Enrollment target
NCT02203331 is a Phase 2 study that has completed, run by Bayer. The registered enrollment target is 319 participants.
The verdict
NCT02203331, a Phase 2 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 319 participants
- Enrollment target
Study Summary
Purpose of the study is to test efficacy and safety of BAY98-7196 intravaginal ring as a new treatment option for patients with endometriosis-associated pelvic pain
Interventions
- DRUG Placebo
- DRUG Anastrozole
- DRUG Levonorgestrel
- DRUG Lupron / Leuprolide acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 319 participants |
| Start Date | 2014-10-16 |
| Est. Completion | 2016-10-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02203331
The ClinicalTrials.gov registry entry for NCT02203331 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 319 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02203331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02203331 about?
NCT02203331 is a clinical study titled "Bay98-7196, Dose Finding / POC Study". Purpose of the study is to test efficacy and safety of BAY98-7196 intravaginal ring as a new treatment option for patients with endometriosis-associated pelvic pain
What is the current status of trial NCT02203331?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 319 participants. The study started on 2014-10-16. Estimated completion is 2016-10-24.
What interventions are being tested in trial NCT02203331?
The interventions under investigation include: Placebo (DRUG), Anastrozole (DRUG), Levonorgestrel (DRUG), Lupron / Leuprolide acetate (DRUG).
Who is sponsoring clinical trial NCT02203331?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.